With its 'Chevron' ruling, the Supreme Court claims to be smarter than scientific experts
By Michael Hiltzik,
LA Times
| 07. 02. 2024
Photo by Claire Anderson on Unsplash
Second only to the Supreme Court’s ruling Monday on when presidents are immune from criminal prosecution, the biggest case of the court’s recently completed session involved the age-old conflict between judges and government regulators.
The case concerned a 40-year-old precedent known as “Chevron deference.” That doctrine held that when a federal law is ambiguous, the courts must defer to the interpretations offered by the agencies the law covers — as long as those interpretations are “reasonable.” On Monday, the court discarded Chevron deference.
This may sound like an abstruse legalistic squabble, but it has massive implications for Americans in all walks of life. It could subject agency decisions on scientifically based issues such as clean air and water regulations and healthcare standards to endless nitpicking by a federal judiciary that already has displayed an alarming willingness to dismiss scientific expertise out of hand, in favor of partisan or religious ideologies.
The ruling amounts to an apogee of arrogance on the part of the Supreme Court’s conservative majority, wrote Justice Elena Kagan in a dissent...
Related Articles
By Rob Stein, NPR | 12.13.2024
Lucy Landman was born with a very rare genetic disorder that causes severe intellectual disability, weak muscles and seizures, among other symptoms.
"She is expected to very much never be able to live independently, likely never be potty trained...
By Kristine Servando, Bloomberg | 12.05.2024
(Bloomberg) — A woman in Hong Kong had to travel to two different countries to attempt conceiving a baby on her own. A gay couple in the city resorted to even bigger extremes: Banned from surrogacy, they turned to the...
By Stefan Bernhardt-Radu, Aeon | 12.02.2024
In the 18th century, European scholars began to envision a more enlightened world in harmony with nature. The old aristocratic regime, some hoped, would soon be replaced by a progressive society in which moral and social values were aligned with...
By Staff, Reuters | 12.04.2024
The Centers for Medicare & Medicaid Services said on Wednesday it had entered into agreements with Vertex Pharmaceuticals (VRTX.O), opens new tab and bluebird bio (BLUE.O), opens new tab to help increase patient access to their gene therapies.
The so-called...